| Name | Title | Contact Details |
|---|
BioAtla was founded in 2007 and employs deep expertise in protein engineering to develop better monoclonal antibody and other protein therapeutics. Our suite of proprietary technologies (protected by more than 70 issued patents and patent applications) has enabled us to develop dozens of novel therapeutic proteins for our partners and our own pipeline. We accelerate the process from target discovery to manufacturing and preclinical studies by creating drugs with more selective targeting, greater affinity, and more cost-efficient and predictable manufacturing. In the process we also create valuable, protectable IP that gives our partners significant competitive advantage. The culmination of our protein evolution technologies is our Conditionally Active Biologics (CAB)platform. Monoclonal antibodies or enzymes can be engineered for selective conditional activation, i.e. the protein`s functions are designed to modulate with changes in microphysical conditions (e.g., pH level, oxidation, temperature, pressure concentration, presence of certain ions, hydrophobicity and competing protein binding). Tumors and other kinds of diseased tissue give rise to unique localized conditions distinct from normal tissue. CAB designed monoclonal antibodies can be programmed to deliver an ADC payload and/or recruit the immune response to specific sites and conditions in the body.
The Hunterdon Healthcare System is a non-profit health care organization in Flemington, NJ committed to providing a full range of quality services that respond to the needs of the community. Hunterdon Medical Center is a 178-bed non-profit community hospital, providing a full range of preventive, diagnostic, and therapeutic inpatient and outpatient hospital and community health services.
Westlake Medical Research is a Westlake Village, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
California MedTech is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clin-X, comprised of three affiliated companies (ClinEdge, BTC Network, and GuideStar Research), provides a full range of clinical and outsourced business services to clinical research institutions, hospitals, pharmaceutical companies, and CROs. Combined, the companies represent four business segments: two global networks of research clinics, consulting and financial management, and patient recruitment and retention. The business segments seamlessly work together to streamline research operations, minimize enrollment timelines, and overall help research institution businesses thrive.